You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 83 No. 1, January 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Three Unusual Pigmentary Syndromes

AARON B. LERNER, M.D., Ph.D.

Arch Dermatol. 1961;83(1):97-105.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We have had the opportunity to examine directly patients with a variety of pigmentary anomalies. In addition, we have corresponded with physicians whose patients have disorders of pigmentation. In the present report 2 unusual types of hyperpigmentation and one of hypopigmentation will be described.

Hyperpigmentation

There are many causes of hyperpigmentation. The present discussion will be confined to hyperpigmentation associated with hyperactivity of the pituitary gland. In Addison's disease or adrenal cortical insufficiency, a characteristic kind of hyperpigmentation develops. Darkening occurs in the exposed areas, body folds, mucous membranes, and sites of recent trauma. There is good evidence that this hyperpigmentation results from increased release of melanocytestimulating hormone (MSH) from the intermediate lobe of the pituitary gland.1,2 The following experiments support this concept: administration of homogenous MSH preparations to man produced skin darkening; urinary excretion of MSH was increased in patients with adrenal cortical insufficiency, and MSH was increased . . . [Full Text PDF of this Article]


Author Affiliations

NEW HAVEN, CONN.

From the Section of Dermatology, Department of Medicine, Yale University School of Medicine.


Footnotes

Submitted for publication June 2, 1960.

Read before the 80th Annual Meeting of the American Dermatological Association, Inc., Boca Raton, Fla., April 8-12, 1960.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.